Neuronetics, Inc. (FRA:NRC)

Market Cap	120.48M -4.4%
Revenue (ttm)	110.69M +78.6%
Net Income	-37.93M
EPS	-0.65
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1
Open	1.812
Previous Close	1.824
Day's Range	1.812 - 1.850
52-Week Range	1.048 - 4.870
Beta	n/a
RSI	57.11
Earnings Date	Mar 4, 2026

About Neuronetics

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company s...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2001
• Employees: 716
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: NRC

Financial Performance

In 2024, Neuronetics's revenue was $74.89 million, an increase of 4.96% compared to the previous year's $71.35 million. Losses were -$43.71 million, 44.8% more than in 2023.

Financial numbers in USD